ALL-442 Patient-reported Outcomes in Adults With Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Treated With Ponatinib or Imatinib in Combination With Reduced-Intensity Chemotherapy: Results From the Phase III PhALLCON Study
Year: 2024
Type: conference-abstract
Institutions: City Of Hope National Medical Center, Hospital Universitari i Politècnic La Fe, University of Alabama at Birmingham, Instituto do Câncer do Estado de São Paulo, Istituto di Ematologia di Bologna, Oregon Health & Science University, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Josep Carreras Leukaemia Research Institute, Hackensack University Medical Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, First Affiliated Hospital Zhejiang University, First Hospital of Jilin University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401875990